NO20014603L - Tienopyrimidinforbindelser, deres fremstilling og anvendelse - Google Patents

Tienopyrimidinforbindelser, deres fremstilling og anvendelse

Info

Publication number
NO20014603L
NO20014603L NO20014603A NO20014603A NO20014603L NO 20014603 L NO20014603 L NO 20014603L NO 20014603 A NO20014603 A NO 20014603A NO 20014603 A NO20014603 A NO 20014603A NO 20014603 L NO20014603 L NO 20014603L
Authority
NO
Norway
Prior art keywords
tienopyrimidine
compounds
preparation
tienopyrimidine compounds
Prior art date
Application number
NO20014603A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014603D0 (no
Inventor
Shuichi Furuya
Nobuhiro Suzuki
Nobuo Choh
Yoshi Nara
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20014603D0 publication Critical patent/NO20014603D0/no
Publication of NO20014603L publication Critical patent/NO20014603L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20014603A 1999-03-24 2001-09-21 Tienopyrimidinforbindelser, deres fremstilling og anvendelse NO20014603L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7937199 1999-03-24
JP2000018019 2000-01-25
PCT/JP2000/001777 WO2000056739A1 (en) 1999-03-24 2000-03-23 Thienopyrimidine compounds, their production and use

Publications (2)

Publication Number Publication Date
NO20014603D0 NO20014603D0 (no) 2001-09-21
NO20014603L true NO20014603L (no) 2001-11-26

Family

ID=26420391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014603A NO20014603L (no) 1999-03-24 2001-09-21 Tienopyrimidinforbindelser, deres fremstilling og anvendelse

Country Status (28)

Country Link
US (1) US6340686B1 (de)
EP (1) EP1163244B1 (de)
JP (1) JP3240293B2 (de)
KR (2) KR100533483B1 (de)
CN (1) CN1349536A (de)
AR (1) AR023152A1 (de)
AT (1) ATE261449T1 (de)
AU (1) AU764019B2 (de)
BR (1) BR0009297A (de)
CA (1) CA2368108C (de)
CZ (1) CZ294747B6 (de)
DE (1) DE60008862T2 (de)
DK (1) DK1163244T3 (de)
ES (1) ES2212992T3 (de)
HK (1) HK1042495B (de)
HU (1) HUP0200550A3 (de)
ID (1) ID30393A (de)
IL (1) IL145549A (de)
MX (1) MXPA01009566A (de)
MY (1) MY124726A (de)
NO (1) NO20014603L (de)
NZ (1) NZ514737A (de)
OA (1) OA11920A (de)
PL (1) PL351202A1 (de)
PT (1) PT1163244E (de)
SK (1) SK13552001A3 (de)
TW (1) TWI225863B (de)
WO (1) WO2000056739A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
WO2001064683A1 (en) * 2000-02-29 2001-09-07 Takeda Chemical Industries, Ltd. Processes for the production of thienopyrimidine derivatives
WO2001078780A1 (en) * 2000-04-13 2001-10-25 Takeda Chemical Industries, Ltd. Preventives/remedies for alzheimer's disease
US20040023987A1 (en) * 2000-06-14 2004-02-05 Yoshio Hata Sustained release compositions
EP1319409A4 (de) * 2000-09-22 2006-05-03 Takeda Pharmaceutical Feste zubereitungen
WO2002043766A1 (en) * 2000-11-29 2002-06-06 Takeda Chemical Industries, Ltd. Medicinal compositions and process for producing the same
AU2002221139A1 (en) * 2000-12-15 2002-06-24 Takeda Chemical Industries Ltd. Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
US20040116522A1 (en) * 2001-03-30 2004-06-17 Yutaka Yamagata Medicinal solutions
WO2003011293A2 (en) 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
WO2003011870A1 (en) * 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists
MXPA04000986A (es) 2001-08-02 2005-02-17 Neurocrine Biosciences Inc 1,2,3-triazin-3,5-dionas sustituidas como antagonistas del receptor de hormona de liberacion de gonadotropina (gnrh).
KR20040030893A (ko) 2001-08-02 2004-04-09 뉴로크린 바이오사이언시즈 인코퍼레이티드 치환된 피리딘-4-온 및 고나도트로핀 분비 호르몬 수용체길항제로서의 이의 용도
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
WO2003064429A1 (en) 2002-01-30 2003-08-07 Takeda Chemical Industries, Ltd. Thienopyrimidines, process for preparing the same and use thereof
WO2003086464A1 (en) 2002-04-12 2003-10-23 Takeda Pharmaceutical Company Limited. Preventives/remedies for hotflash
DE60318716T2 (de) * 2002-08-21 2009-01-08 Astrazeneca Ab Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
PT1591446E (pt) 2003-01-29 2013-06-12 Takeda Pharmaceutical Compostos de tienopirimidina e sua utilização
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
US20060083017A1 (en) * 2004-10-18 2006-04-20 Bwt Propety, Inc. Solid-state lighting apparatus for navigational aids
KR20080041662A (ko) * 2005-07-22 2008-05-13 다케다 야쿠힌 고교 가부시키가이샤 조기 배란 예방제
WO2010026993A1 (ja) 2008-09-03 2010-03-11 武田薬品工業株式会社 製剤における吸収性改善方法および吸収性が改善された製剤
MX357841B (es) * 2012-02-28 2018-07-26 Tiumbio Co Ltd Antagonistas de los receptores de la hormona liberadora de gonadotropina, método para la preparación de éstos y composición farmacéutica que los contienen.
PT3415517T (pt) 2012-09-28 2022-05-13 Takeda Pharmaceuticals Co Forma cristalina de 1-(4-1-(2,6-difluorobenzil)-5- dimetilaminometil-3-(6-metoxipiridazin-3-il)-2,4-dioxo- 1,2,3,4-tetrahidrotieno(2,3-d)-pirimidin-6-il)fenil)-3- metoxiureia
FI3263110T3 (fi) * 2015-02-26 2023-07-25 Takeda Pharmaceuticals Co Tabletti, joka käsittää metoksiureajohdannaista ja mannitolipartikkeleita
ES2912929T5 (en) 2016-09-30 2025-05-09 Sumitomo Pharma Switzerland Gmbh Methods of treating uterine fibroids and endometriosis
EP3518932B1 (de) 2016-09-30 2024-11-13 Sumitomo Pharma Switzerland GmbH Prostatakrebsbehandlung
KR101973074B1 (ko) * 2018-11-30 2019-04-26 주식회사 티움바이오 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물
EP4004001B1 (de) * 2019-07-29 2025-09-03 Sunshine Lake Pharma Co., Ltd. Substituierte pyrimidindionverbindungen und verwendungen davon
CN115279769A (zh) 2019-10-10 2022-11-01 梦欧文科学有限责任公司 N-(4-(1-(2,6-二氟苄基)-5-((二甲基氨基)甲基)-3-(6-甲氧基-3-哒嗪基)-2,4-二氧代-1,2,3,4-四氢噻吩并[2,3-d]嘧啶-6-基)苯基)-n’-甲氧基脲的结晶形式
CN111574534B (zh) * 2020-05-25 2021-06-04 东莞市东阳光新药研发有限公司 苯基取代的噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮类化合物及其用途
CA3185151A1 (en) 2020-05-29 2021-12-02 Myovant Sciences Gmbh Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists
CN111925379B (zh) * 2020-07-31 2022-02-15 广东东阳光药业有限公司 含氮杂芳基取代的嘧啶二酮类化合物及其用途
CN111909168B (zh) * 2020-07-31 2022-02-01 广东东阳光药业有限公司 含氮杂环基取代的嘧啶二酮类化合物及其用途
CN113754679B (zh) * 2020-09-09 2023-04-07 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN112047957B (zh) * 2020-09-09 2022-02-01 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN113563304B (zh) * 2020-12-30 2022-06-28 上海博志研新药物技术有限公司 瑞卢戈利中间体及其制备方法
CN115260211B (zh) * 2021-04-29 2024-02-06 长春金赛药业有限责任公司 含噻吩稠环类衍生物、药物组合物及其制备方法和应用
CN113717149A (zh) * 2021-09-29 2021-11-30 成都伊诺达博医药科技有限公司 一种瑞卢戈利关键中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW449600B (en) * 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
UY23948A1 (es) * 1995-02-08 2001-10-25 Takeda Chemical Industries Ltd Derivados de anillos condensados de tiofeno su producción y uso.
US5627786A (en) * 1995-02-10 1997-05-06 Micron Quantum Devices, Inc. Parallel processing redundancy scheme for faster access times and lower die area
EP0816316A4 (de) * 1995-03-10 1999-06-02 Nitto Chemical Industry Co Ltd Verfahren zur herstellung von 1,2-ethandiolderivaten

Also Published As

Publication number Publication date
CA2368108A1 (en) 2000-09-28
JP3240293B2 (ja) 2001-12-17
KR20010015920A (ko) 2001-02-26
WO2000056739A1 (en) 2000-09-28
TWI225863B (en) 2005-01-01
ES2212992T3 (es) 2004-08-16
CN1349536A (zh) 2002-05-15
ID30393A (id) 2001-11-29
KR20010090430A (ko) 2001-10-18
OA11920A (en) 2006-04-12
NZ514737A (en) 2003-10-31
DE60008862T2 (de) 2005-01-27
DE60008862D1 (de) 2004-04-15
HUP0200550A3 (en) 2004-07-28
BR0009297A (pt) 2001-12-18
SK13552001A3 (sk) 2002-03-05
CA2368108C (en) 2009-12-22
ATE261449T1 (de) 2004-03-15
MY124726A (en) 2006-06-30
EP1163244A1 (de) 2001-12-19
PL351202A1 (en) 2003-03-24
NO20014603D0 (no) 2001-09-21
KR100370981B1 (ko) 2003-02-06
DK1163244T3 (da) 2004-07-12
AU3326200A (en) 2000-10-09
EP1163244B1 (de) 2004-03-10
US6340686B1 (en) 2002-01-22
HK1042495B (en) 2004-10-08
IL145549A (en) 2005-11-20
IL145549A0 (en) 2002-06-30
JP2001278884A (ja) 2001-10-10
AU764019B2 (en) 2003-08-07
CZ20013419A3 (cs) 2002-02-13
HK1042495A1 (en) 2002-08-16
PT1163244E (pt) 2004-07-30
HUP0200550A2 (en) 2002-06-29
AR023152A1 (es) 2002-09-04
CZ294747B6 (cs) 2005-03-16
MXPA01009566A (es) 2002-05-14
KR100533483B1 (ko) 2005-12-05

Similar Documents

Publication Publication Date Title
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20015113L (no) Nye forbindelser, deres fremstilling og anvendelse
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20011956D0 (no) Substituerte fenylderivater, deres fremstilling og anvendelse
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
EE200200150A (et) Preparaat
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20023146D0 (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
NO20020156D0 (no) Titanavledede forbindelser, fremstilling og anvendelse derav
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20001782L (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse
NO20012802D0 (no) Benzofuranderivater, deres fremstilling og anvendelse
NO20011921L (no) Sulfidoamidokarboksylsyre, deres fremstilling og anvendelse